Skip to main content
. 2014 Sep 17;9(9):e107704. doi: 10.1371/journal.pone.0107704

Table 2. Resource utilization and costs of patients with Parkinson's disease in Hungary.

Resource utilisation Average yearly cost, EUR/patient/year
Rate of patients with at least one occasion (%) Mean of the quantity used in the past 12 months (n = 109) Cost per patient (total sample) Cost category (total sample)
Consultations (outpatient) - - 50.9 Direct medical cost: 2149.3 Euro/patient/year (35.7%)
GP visit 68 (62.3%) 3.3 17.8
Specialist visit 100 (91.7%) 4.9 33.1
Hospital admission 37 (33.9%) 0.4 348.4
Diagnostics - - 42.5
CT scan 68 (62.4%) 0.4 8.0
MRI scan 54 (49.5%) 0.2 11.4
SPECT 17 (15.6%) 0.04 17.8
Laboratory tests 67 (601.5%) 0.8 0.7
X-ray 28 (25.7%) 0.1 0.5
Neuropsychology 41 (37.6%) 0.3 3.4
Doppler 21 (19.3%) 0.1 0.4
Tremor analysis 18 (16.5%) 0.1 0.2
Tests of autonomic functions 21 (19.3%) 0.2 0,1
Drugs (present users) - - 1614.3
MAO-B inhibitor 35 (32.1%) 179.1
Amantadine 29 (26.6%) 33.5
Anticholinergic drug 4 (3.7%) 3.9
Dopamin agonist 50 (45.9%) 484.7
Levodopa+decarboxylase inhibitor 59 (54.1%) 117.9
Levodopa+decarboxylase inhibitor+COMT inhibitor 34 (31.2%) - 535.0
COMT-inhibitor 18 (16.5%) - 260.2
Other health care services - - 93.2
Not reimbursed services 19 (17.4%) - 57.2
Ambulance 8 (7.3%) 0.2 36.0
Non-medical cares - - 1774.6 Direct non-medical cost: 1774.6 EUR (29.4%)
Transportation 92 (84.45%) - 69.9
Informal care 47 (43.1%) 12.6 hours/week 1704.7
Productivity loss - - 2106.3 Indirect cost: 2106.3 EUR (34.9%)
Work disability pension* 19 (17.4%) NA 2002.7
Sick leave 5 (4.6%) 1.6 days/year 75.1
Part time job due to PD 1 (0.9%) NA 28.5
Total NA NA NA 6030.2 EUR

For cost of drugs see also Table S2.

(N = 109; conversion €1 = 280.6 HUF);

* All of them are on disability pension due to their Parkinson's disease.